Form 4: Galecto Director Receives Stock Grant
Insider Transaction (Form 4)
Andrew Cheng, a Director of Galecto, Inc., received 30,350 shares of common stock on August 12, 2026.
Summary
- Grant/award: acquired 30,350 Stock Option (right to buy) on August 12, 2026; holds 30,350 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew Cheng — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Grant/award | Stock Option (right to buy) | 30,350 | — | — | 30,350 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Grant/award (30,350 shares) |
Keywords
insider transaction, Form 4, DMRA, Damora Therapeutics, Inc., neutral, Andrew Cheng
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.